|
|||||||||
|
|||||||||
 | |||||||||
 | |||||||||
|
Sitaxsentan improved 6-minute walk distance and quality of life in connective tissue disease patients who also have PAH... Rheumatology News TNF inhibitors are not better than traditional DMARDs at preventing MI in rheumatoid arthritis (RA) patients, but lower heart attack rates in those who respond to TNF-blockers support the hypothesis that inflammation plays a role in the increased MI risk associated with RA... Rheumatology News B- and T-cell targeted therapies as well as other biologic drugs may change the way primary Sjögren’s syndrome is treated in the future...
Abbott Laboratories announced positive study data from an extension to a phase II study demonstrating that a majority of moderate-to-severe psoriasis patients who responded to anti-IL-12/23 (ABT-874) after 12 weeks of treatment maintained a high level of response at 24 weeks, following discontinuation of therapy... Centocor, Inc, a wholly owned subsidiary of Johnson & Johnson, announced findings from an international, randomized, double-blind, placebo-controlled phase III study involving 1230 subjects... |
|
 |
|
 Rheumatology and Infusion Therapy: Practice and Treatment Choices in the New Era | |
 The Scientific Basis of Individualized Treatment of Patients With RA: Online Byte-Size CME | |
To remove your e-mail address from our mailing list, please send a blank email to unsubscribe@fbhc.org. For questions and comments regarding this newsletter please contact info@ciaomed.org | |
